NUSCA, ANNUNZIATA
 Distribuzione geografica
Continente #
AS - Asia 5.888
NA - Nord America 1.962
EU - Europa 981
SA - Sud America 142
OC - Oceania 43
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.058
Nazione #
SG - Singapore 4.796
US - Stati Uniti d'America 1.899
CN - Cina 569
IT - Italia 439
HK - Hong Kong 174
BR - Brasile 99
BD - Bangladesh 97
GB - Regno Unito 95
DE - Germania 93
FR - Francia 92
VN - Vietnam 92
NL - Olanda 63
EE - Estonia 46
IN - India 44
AU - Australia 42
CZ - Repubblica Ceca 42
CA - Canada 35
AR - Argentina 19
FI - Finlandia 19
MX - Messico 18
ID - Indonesia 16
ZA - Sudafrica 15
TR - Turchia 13
JP - Giappone 12
RU - Federazione Russa 12
PK - Pakistan 11
PH - Filippine 10
ES - Italia 9
BE - Belgio 8
MA - Marocco 8
RO - Romania 8
AT - Austria 7
IQ - Iraq 7
IR - Iran 7
MY - Malesia 7
SA - Arabia Saudita 7
SE - Svezia 7
MD - Moldavia 6
CO - Colombia 5
EC - Ecuador 5
JM - Giamaica 5
UA - Ucraina 5
CH - Svizzera 4
LT - Lituania 4
NO - Norvegia 4
PE - Perù 4
PL - Polonia 4
TW - Taiwan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
DZ - Algeria 3
TN - Tunisia 3
UZ - Uzbekistan 3
BG - Bulgaria 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
LU - Lussemburgo 2
MN - Mongolia 2
PT - Portogallo 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
FJ - Figi 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
IE - Irlanda 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
RE - Reunion 1
RS - Serbia 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.058
Città #
Ashburn 652
San Jose 495
Singapore 402
Rome 269
Hong Kong 171
Dallas 159
Beijing 146
Hefei 140
Boardman 90
Lauterbourg 69
London 58
Amsterdam 45
Tallinn 45
Council Bluffs 42
Shanghai 40
Los Angeles 38
Munich 37
Brno 31
Ho Chi Minh City 27
New York 25
Santa Clara 24
Perth 22
Milan 21
San Francisco 21
Hanoi 19
Seattle 16
Washington 15
Xi'an 13
Brooklyn 11
Helsinki 11
Montreal 11
São Paulo 10
West Jordan 10
Chicago 9
Frankfurt am Main 9
Mexico City 9
Olomouc 9
Tokyo 9
Bengaluru 8
Bologna 8
Jinan 8
Melbourne 8
Nuremberg 8
Rio de Janeiro 8
Chennai 7
Orem 7
Pune 7
Turku 7
Bocholt 6
Hangzhou 6
Hanover 6
Las Vegas 6
Manchester 6
The Dalles 6
Toronto 6
Buffalo 5
Johannesburg 5
Naples 5
Palermo 5
Philadelphia 5
Qingdao 5
Staten Island 5
Zhengzhou 5
Atlanta 4
Da Nang 4
Florence 4
Guangzhou 4
Haiphong 4
Porto Alegre 4
Quezon City 4
Stockholm 4
Târgu Mureş 4
Ankara 3
Aubin Grove 3
Borås 3
Boston 3
Casablanca 3
Changsha 3
Conroe 3
Curitiba 3
Genoa 3
George Town 3
Guayaquil 3
Kingston 3
Lahore 3
Miami 3
Ribeirão Preto 3
Santiago 3
Seichamps 3
Shenyang 3
Shenzhen 3
Stuttgart 3
Taipei 3
Tashkent 3
Thrissur 3
Vienna 3
Aberdeen 2
Ambāla 2
Aracaju 2
Armenia 2
Totale 3.504
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 444
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 271
Characterization of inflammatory profile by breath analysis in chronic coronary syndromes 244
Current management and prognosis of patients with recurrent myocardial infarction 240
3D transesophageal echocardiographic assessment of acute reverse remodeling of the tricuspid annulus after transcatheter edge-to-edge repair 238
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 238
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 238
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 234
[The hybrid strategy for complete myocardial revascularization in the frail elderly patient]. 231
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 229
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 225
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 223
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 223
Changes of the Coronary Arteries and Cardiac Microvasculature With Aging: Implications for Translational Research and Clinical Practice 221
Carcinoid Pulmonary Valve Stenosis: Multimodality Imaging and Transcatheter Valve Implant With Prestenting Technique 219
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when? 213
Dexamethasone-eluting stents attenuate endothelial activation in patients with unstable coronary syndromes 202
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 202
Dissecting intramyocardial hematoma masquerading as a pseudoaneurysm of left ventricular free wall: an unusual case of myocardial rupture 196
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 192
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 173
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 144
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 144
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 143
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 134
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 124
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 120
Correction to: The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 119
Incidence, diagnosis, and prognosis of myocarditis: does gender matter? 115
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty 115
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 113
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 113
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 113
Glycemic variability in the development of cardiovascular complications in diabetes 110
Correlation between glycemic variability assessed by CGM and short-term outcome in patients undergoing percutaneous coronary intervention 109
Invasive Assessment of Coronary Microvascular Function 107
The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review 104
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 101
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality-A Comprehensive Review 96
Classification of Aortic Stenosis Patients via ECG-Independent Multi-Site Measurements of Cardiac-Induced Accelerations and Angular Velocities at the Skin Level 92
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 90
Instantaneous wave-free ratio-guided revascularization of non-culprit lesion in patients with ST-segment elevation myocardial infarction and multivessel coronary disease: design and rationale of the WAVE Registry 80
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 77
Cardiac involvement of Gorlin-Goltz syndrome: new light among the shadows of an old congenital disorder 73
Eosinophilic Myocarditis: From Bench to Bedside 69
Platelet function and markers of atherothrombotic risk in individuals with parathyroid disorders 68
The butterfly effect: Restoring the tricuspid coaptation after clipping the antero-septal commissure 65
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 62
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 59
Role of polypill in cardiovascular prevention and treatment 59
Indirect respiratory monitoring via single-lead wearable ECG: Influence of motion artifacts and devices on respiratory rate estimations 58
Tricuspid Valve Geometrical Changes in Patients with Functional Tricuspid Regurgitation: Insights from a CT Scan Analysis Focusing on Commissures 56
The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 56
Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis 55
Novel Antidiabetic Agents and Their Effects on Lipid Profile: A Single Shot for Several Cardiovascular Targets 50
The Role of SGLT2-Inhibitors Across All Stages of Heart Failure and Mechanisms of Early Clinical Benefit: From Prevention to Advanced Heart Failure 50
Rethinking weight loss treatments as cardiovascular medicine in obesity, a comprehensive review 50
Percutaneous Repair of Atrial Functional Tricuspid Regurgitation in Cardiac Amyloidosis: Combining Linear With Lateral Thinking 47
Who is the next for aortic valve implantation? Present and future indications 47
Early prediction of contrast-induced acute kidney injury by a "bedside" assessment of Neutrophil Gelatinase-Associated Lipocalin during elective percutaneous coronary interventions 47
Double anterograde/retrograde approach for embolization of pulmonary arteriovenous malformation presenting with acute respiratory failure 46
Current and Emerging Roles of GLP1 Receptor Agonists Across the Spectrum of Left Ventricular Ejection Fraction in Heart Failure 46
Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease 44
Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis 43
Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention 43
Functional Mitral and Tricuspid Regurgitation across the Whole Spectrum of Left Ventricular Ejection Fraction: Recognizing the Elephant in the Room of Heart Failure 42
SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness 42
Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention 41
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 40
Novel Computed Tomography Variables for Assessing Tricuspid Valve Morphology: Results from the TRIMA (Tricuspid Regurgitation IMAging) Study 37
Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy 36
Protection from procedural myocardial injury by pre-treatment with atorvastatin is associated with lower expression of adhesion molecules after percutaneous coronary intervention 36
The Role of Cardiac Troponin and Other Emerging Biomarkers Among Athletes and Beyond: Underlying Mechanisms, Differential Diagnosis, and Guide for Interpretation 35
Influence of Sampling Frequency on the Symmetric Projection Attractor Reconstruction 33
PTH-driven modulation of platelet activity via the NOX2 pathway in postsurgical hypoparathyroidism 32
Seismocardiogram Classification Based on Symmetric Projection Attractor Reconstruction Analysis to Enhance Hemodynamic Variables Estimation 31
Sodium-Glucose Transporter-2 Inhibitors (SGLT2i) and Myocardial Ischemia: Another Compelling Reason to Consider These Agents Regardless of Diabetes 31
Short-Term Percutaneous Mechanical Circulatory Support in Acute Coronary Syndrome with Cardiogenic Shock: Which Device to Choose? 30
Towards Non-Invasive Hemodynamic Monitoring: A Feasibility Analysis of Left Ventricular Ejection Time (LVET) Measurement with Wearable Inertial Sensors in Aortic Stenosis Patients 28
Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials. 28
Single-territory incomplete surgical revascularization improves regional wall motion of remote ventricular areas: results from a propensity-matched study. 28
Anthropometric Indices and Markers of Atherothrombotic Risk in Subjects with Primary Hyperparathyroidism 13
Assessment of Single-Lead Ecg Signal Quality in Wearable Devices: Comparison between Chest Straps and Adhesive Patch 4
Multi-site seismocardiographic measurements for the estimation of cardiac output in patients with aortic stenosis 2
Totale 9.121
Categoria #
all - tutte 36.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202262 0 0 2 0 2 0 0 0 0 0 9 49
2022/202394 2 1 16 11 13 2 0 2 1 0 46 0
2023/2024641 1 27 31 31 21 97 51 272 20 42 10 38
2024/20255.134 84 32 90 96 33 84 73 17 141 285 2.009 2.190
2025/20263.177 253 153 198 217 199 227 804 185 271 337 224 109
2026/202713 13 0 0 0 0 0 0 0 0 0 0 0
Totale 9.121